Review Article

Yoga for Adults with Type 2 Diabetes: A Systematic Review of Controlled Trials

Table 4

Recent published meta-analyses regarding effects of yoga on risk indices relevant to T2DM, summarized findings.

MeasureFirst author, yearPopulationIncluded studiesComparatorMean difference (95% CI)
DesignNumberTotal Pts

Glucose tolerance
Fasting blood glucose (mg/dL)Cramer, 2014 [34]DM2 RCTs7525Usual care−25.56 (−39.60, −11.53)<0.01
Chu, 2014 [71]DM or MSRCTs6315All −8.77 (−26.77, 9.23)0.34
HbA1cCramer, 2014 [34]DM2RCTs7550Usual care −0.49 (−1.03, 0.05)0.07
Lipid profiles
Total cholesterolCramer, 2014 [34]DM2RCTs5516Usual care−13.09 (−19.60, −6.59)<0.01
Cramer, 2014 [34]DM2RCTs2317Exercise−8.08 (−19.20, 3.03)0.21
Chu, 2014 [71]DM or MSRCTs5365All−20.98 (−33.23, −8.72)0.0008
Chu, 2014 [71]CVD risk factorsRCTs2109All−18.85 (−37.24, −0.46)0.04
HDL Cramer, 2014 [34]DM2RCTs5516Usual care5.51 (3.56, 7.47)<0.01
Cramer, 2014 [34]DM2RCTs2317Exercise4.24 (1.75, 6.72)0.01
Chu, 2014 [71]DM or MSRCTs5365All2.45 (−0.33, 5.24)0.08
Chu, 2014 [71]CVD risk factorsRCTs2109All3.95 (1.69, 6.21)0.0006
LDLCramer, 2014 [34]DM2RCTs5515Usual care −10.26 (−20.85, 0.32)0.06
Cramer, 2014 [34]DM2RCTs2317Exercise−9.24 (−16.55, −1.93)0.01
Chu, 2014 [71]DM or MSRCTs5365All −21.27 (−32.93, −9.62)<0.00001
Chu, 2014 [71]CVD risk factorsRCTs2109All −14.42 (−20.47, −8.36)0.0003
VLDLCramer, 2014 [34]DM2RCTs2308Usual care−4.81 (−6.67, −2.96)<0.01
TriglyceridesCramer, 2014 [34]DM2RCTs5509Usual care −23.60 (−36.78, −10.43)<0.01
Cramer, 2014 [34]DM2RCTs2317Exercise−22.98 (−60.97, 15.00)0.24
Chu, 2014 [71]DM or MSRCTs5365All−18.61 (−32.61, −4.60)0.009
Chu, 2014 [71]CVD risk factorsRCTs2109All−27.47 (−60.09, 5.15)0.10
Body composition
Waist-hip ratioCramer, 2014 [34]DM2RCTs3311Usual care−0.02 (−0.03, −0.00)<0.01
BMIChu, 2014 [71]DM or MSRCTs3155All −1.63 (−2.25, −1.01)<0.00001
Chu, 2014 [71]CVD risk factorsRCTs277All −0.99 (−2.38, 0.40)0.16
Weight (kg)Chu, 2014 [71]DM or MSRCTs3151All −3.27 (−4.99, −1.54)0.0002
Chu, 2014 [71]CVD risk factorsRCTs6273All −1.95 (−5.25, 1.35)0.25
Blood pressure (BP) (mmHg)
Systolic BP Cramer, 2014 [34]DM2RCTs3237Usual care−6.87 (−14.68, 0.94)0.08
Cramer, 2014 [34]Non-DM high risk RCTs8347Usual care−10.00 (−16.42, −3.59)<0.01
Cramer, 2014 [72]HTRCTs6278Usual care−9.65 (−17.66, −2.06)0.01
Hagins, 2013 [73]HT (all)RCTs, NRCTs11431Usual care−7.96 (−10.65, −5.27)0.0002
Hagins, 2013 [73]HT (Y incl M, PR, AS)RCTs, NRCTs13656All −8.17 (−12.45, −3.89)NR
Hagins, 2013 [73]HT (Y > 58.9 h)RCTs, NRCTs6215All −9.73 (−17.66, −1.79)NR
Chu, 2014 [71]DM or MSRCTs380All −9.39 (−15.14, −3.63)0.001
Chu, 2014 [71]CVD risk factorsRCTs10461All −7.36 (−13.39, −1.33)0.001
Diastolic BP Cramer, 2014 [34]DM2RCTs2210Usual care−0.79 (−5.22, 3.65)0.73
Cramer, 2014 [34]Non-DM high risk RCTs8347Usual care−7.45 (−12.70, −2.21)<0.01
Cramer, 2014 [72]HTRCTs6278Usual care−7.22 (−12.83, −1.62)0.01
Hagins, 2013 [73]HT (all)RCTs, NRCTs11431Usual care−6.14 (−9.39, −2.89)NR
Hagins, 2013 [73]HT (Y incl M, PR, AS)RCTs, NRCTs13656All −5.52 (−7.92, −3.11)NR
Chu, 2014 [71]DM or MSRCTs380All −5.41 (−8.82, −2.01)0.002
Chu, 2014 [71]CVD risk factorsRCTs10461All −6.97 (−11.80, −2.13)0.005
Autonomic fxn
Heart rateCramer, 2014 [34]Non-DM high risk RCTs3133Usual care−10.89 (−22.83, 1.04)0.07

AS: asana, CAD: coronary artery disease, CI: confidence interval, CVD: cardiovascular disease, fxn: function, HT: hypertension, M: meditation, MS: metabolic syndrome, NR: not reported, NRCT: nonrandomized controlled trial, PR: pranayama, Pts: participants, and Y: yoga.